Marathon Nextgen Realty Limited
MARATHON (NSE) · MARATHON (BSE 503101) · ISIN INE182D01020 · Residential Commercial Projects · Est. 1978 · listed 2016 · website
Not on any surveillance list
In Q2 FY27 (quarter to 30 September 2026, standalone), revenue was ₹62.04 cr and profit after tax ₹47.79 cr. Revenue was 1.1% lower than in Q2 FY26.
Next: Board meeting: Other business matters Board Meeting Intimation for New/Additional Investments In Projects / SPV'S And Any Other Matter on 27 October 2026.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q2 FY27 standalone | ₹62.04 cr | ₹47.79 cr | 7.08 | 21 Oct 2026 |
| Q1 FY27 standalone | ₹39.25 cr | ₹36.62 cr | 5.43 | 7 Aug 2026 |
| Q4 FY26 standalone | ₹68.21 cr | ₹59.28 cr | 8.79 | 27 May 2026 |
| Q3 FY26 standalone | ₹21.94 cr | ₹27.87 cr | 4.13 | 13 Feb 2026 |
| Q2 FY26 standalone | ₹62.7 cr | ₹60.51 cr | 8.97 | 4 Feb 2026 |
| Q1 FY26 standalone | ₹23.93 cr | ₹41.87 cr | 8.17 | 11 Aug 2025 |
| Q4 FY25 standalone | ₹73.7 cr | ₹40.98 cr | 8.00 | 21 May 2025 |
| Q3 FY25 standalone | ₹168.24 cr | ₹94.78 cr | 18.50 | 17 Mar 2025 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 30 Sep 2026 standalone | ₹2,240.86 cr | ₹8.72 cr | ₹2,290.3 cr |
| 31 Mar 2026 standalone | ₹2,162.88 cr | ₹1.18 cr | ₹2,207.44 cr |
| 30 Sep 2025 standalone | ₹2,075.66 cr | ₹0.21 cr | ₹2,138.28 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 56.40% | 2.59% | 14.47% | 43.60% |
Other companies in Residential Commercial Projects
- Lodha Developers Limited
- Sobha Limited
- Oberoi Realty Limited
- Prestige Estates Projects Limited
- DLF Limited
- Brigade Enterprises Limited
- Puravankara Limited
- Raymond Realty Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 21 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.